Advances and applications of multiomics technologies in precision diagnosis and treatment for gastric cancer
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · 2025-07 · 1880 (3) · 189336
DOI: 10.1016/j.bbcan.2025.189336 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2025-07. Verfasst von Ke Shen und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastric Surgery, Zhejiang Cancer Hospital, Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou, Zhejiang 310022…. Hauptthemen laut MEDLINE: Stomach Neoplasms, Precision Medicine, Biomarkers, Tumor, Genomics. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 200 Literaturangaben. Gefördert von: Science and Technology Program of Zhejiang Province, National Natural Science Foundation of China, China Postdoctoral Science Foundation.
Abstract (Originalsprache)
Gastric cancer (GC), one of the most prevalent malignancies worldwide, is distinguished by extensive genetic and phenotypic heterogeneity, posing persistent challenges to conventional diagnostic and therapeutic strategies. The significant global burden of GC highlights an urgent need to unravel its complex underlying mechanisms, discover novel diagnostic and prognostic biomarkers, and develop more effective therapeutic interventions. In this context, this review comprehensively examines the transformative roles of cutting-edge technologies, including radiomics, pathomics, genomics, transcriptomics, epigenomics, proteomics, and metabolomics, in advancing precision diagnosis and treatment for GC. Multiomics data analysis not only deepens our understanding of GC pathogenesis and molecular subtypes but also identifies promising biomarkers, facilitating the creation of tailored therapeutic approaches. Additionally, integrating multiomics approaches holds immense potential for elucidating drug resistance mechanisms, predicting patient outcomes, and uncovering novel therapeutic targets, thereby laying a robust foundation for precision medicine in the comprehensive management of GC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Gastric Surgery, Zhejiang Cancer Hospital, Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou, Zhejiang 310022, China; Postgraduate Training Base Alliance of Wenzhou Medical Univer…
- Department of Gastric Surgery, Zhejiang Cancer Hospital, Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou, Zhejiang 310022, China; Key Laboratory of Prevention, Diagnosis and Therapy of Upper…
Förderung
- Science and Technology Program of Zhejiang Province
- National Natural Science Foundation of China
- China Postdoctoral Science Foundation
- Zhejiang Province Natural Science Foundation
- National Key Research and Development Program of China
- Innovative Research Group Project of the National Natural Science Foundation of China
Zitieren
APA
Shen, K., Hu, C., Zhang, Y., Cheng, X., Xu, Z., & Pan, S. (2025). Advances and applications of multiomics technologies in precision diagnosis and treatment for gastric cancer. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, 1880(3), 189336. https://doi.org/10.1016/j.bbcan.2025.189336
Vancouver
Shen K, Hu C, Zhang Y, Cheng X, Xu Z, Pan S. Advances and applications of multiomics technologies in precision diagnosis and treatment for gastric cancer. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 2025;1880(3):189336. doi:10.1016/j.bbcan.2025.189336
BibTeX
@article{Shen2025,
author = {Shen, Ke and Hu, Can and Zhang, Yanqiang and Cheng, Xiangdong and Xu, Zhiyuan and Pan, Siwei},
title = {Advances and applications of multiomics technologies in precision diagnosis and treatment for gastric cancer},
journal = {Biochimica et Biophysica Acta (BBA) - Reviews on Cancer},
year = {2025},
volume = {1880},
number = {3},
pages = {189336},
doi = {10.1016/j.bbcan.2025.189336}
}
EUVIMED